{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:53:27Z","timestamp":1773968007036,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","issue":"5","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1111\/tri.13112","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T10:32:59Z","timestamp":1516703579000},"page":"503-509","source":"Crossref","is-referenced-by-count":5,"title":["Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study"],"prefix":"10.3389","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-2016","authenticated-orcid":false,"given":"Rob","family":"Bielen","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Life Sciences; Hasselt University; Hasselt Belgium"},{"name":"Department of Gastroenterology and Hepatology; Ziekenhuis Oost Limburg; Genk Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Robaeys","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Life Sciences; Hasselt University; Hasselt Belgium"},{"name":"Department of Gastroenterology and Hepatology; Ziekenhuis Oost Limburg; Genk Belgium"},{"name":"Department of Gastroenterology & Hepatology; University Hospitals KULeuven; Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Schelfhout","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology; University Hospitals KULeuven; Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diethard","family":"Monbaliu","sequence":"additional","affiliation":[{"name":"Department of Abdominal Transplant Surgery; University Hospitals KULeuven; Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schalk","family":"Van der Merwe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology; University Hospitals KULeuven; Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Pirenne","sequence":"additional","affiliation":[{"name":"Department of Abdominal Transplant Surgery; University Hospitals KULeuven; Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology; University Hospitals KULeuven; Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"10.1111\/tri.13112-BIB0001|tri13112-cit-0001","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2012.10.016","article-title":"Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes","volume":"58","author":"Burra","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/tri.13112-BIB0002|tri13112-cit-0002","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1016\/j.transproceed.2010.07.011","article-title":"Outcomes of long-term administration of intravenous hepatitis B immunoglobulins for the prevention of recurrent hepatitis B after liver transplantation","volume":"42","author":"Pauwelyn","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.13112-BIB0003|tri13112-cit-0003","first-page":"CD006005","article-title":"Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation","author":"Katz","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/tri.13112-BIB0004|tri13112-cit-0004","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/j.gastro.2011.06.083","article-title":"Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation","volume":"141","author":"Fung","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1111\/tri.13112-BIB0005|tri13112-cit-0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"EASL clinical practice guidelines: liver transplantation","volume":"64","author":"Burra","year":"2016","journal-title":"J Hepatol"},{"key":"10.1111\/tri.13112-BIB0006|tri13112-cit-0006","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/TP.0000000000000777","article-title":"Rational basis for optimizing short and long-term hepatitis B virus prophylaxis post liver transplantation: role of hepatitis B immune globulin","volume":"99","author":"Roche","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.13112-BIB0007|tri13112-cit-0007","doi-asserted-by":"crossref","first-page":"e104480","DOI":"10.1371\/journal.pone.0104480","article-title":"Is hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1111\/tri.13112-BIB0008|tri13112-cit-0008","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-6143.2012.04315.x","article-title":"High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review","volume":"13","author":"Cholongitas","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13112-BIB0009|tri13112-cit-0009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/lt.23600","article-title":"Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates","volume":"19","author":"Gane","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.13112-BIB0010|tri13112-cit-0010","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/TP.0000000000001786","article-title":"Short course of postoperative hepatitis B immunoglobulin plus antivirals prevents reinfection of liver transplant recipients","volume":"101","author":"Radhakrishnan","year":"2017","journal-title":"Transplantation"},{"key":"10.1111\/tri.13112-BIB0011|tri13112-cit-0011","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1002\/hep.22885","article-title":"Side effects of long-term oral antiviral therapy for hepatitis B","volume":"49","author":"Fontana","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/tri.13112-BIB0012|tri13112-cit-0012","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/hep.23788","article-title":"Drug therapy: tenofovir","volume":"52","author":"Lok","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/tri.13112-BIB0013|tri13112-cit-0013","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1007\/s10620-015-4027-8","article-title":"Effectiveness and safety of tenofovir disoproxil fumarate in chronic hepatitis B: a 3-year, prospective, real-world study in France","volume":"61","author":"Marcellin","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1111\/tri.13112-BIB0014|tri13112-cit-0014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.13659","article-title":"Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients","volume":"44","author":"Lampertico","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/tri.13112-BIB0015|tri13112-cit-0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4254\/wjh.v9.i5.227","article-title":"Adverse effects of oral antiviral therapy in chronic hepatitis B","volume":"9","author":"Kayaaslan","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1111\/tri.13112-BIB0016|tri13112-cit-0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2016.08.008","article-title":"Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)\/TDF in lamivudine resistant hepatitis B: a 5-year randomised study","volume":"66","author":"Fung","year":"2017","journal-title":"J Hepatol"},{"key":"10.1111\/tri.13112-BIB0017|tri13112-cit-0017","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1007\/s10620-015-3960-x","article-title":"Effectiveness and safety of tenofovir disoproxil fumarate in chronic hepatitis B: a 3-year prospective field practice study in Germany","volume":"61","author":"Petersen","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1111\/tri.13112-BIB0018|tri13112-cit-0018","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13112-BIB0019|tri13112-cit-0019","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lt.21149","article-title":"Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT)","volume":"13","author":"Ruiz","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.13112-BIB0020|tri13112-cit-0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0012.2005.00447.x","article-title":"Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels","volume":"20","author":"Morard","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.13112-BIB0021|tri13112-cit-0021","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/lt.21827","article-title":"Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial","volume":"15","author":"De Simone","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.13112-BIB0022|tri13112-cit-0022","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1399-0012.2003.00044.x","article-title":"Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation","volume":"17","author":"Faust","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.13112-BIB0023|tri13112-cit-0023","first-page":"373","article-title":"Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation","volume":"101","author":"Marzano","year":"2010","journal-title":"Minerva Med"},{"key":"10.1111\/tri.13112-BIB0024|tri13112-cit-0024","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/j.gastro.2007.01.005","article-title":"Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation","volume":"132","author":"Gane","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/tri.13112-BIB0025|tri13112-cit-0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00228-006-0137-8","article-title":"Pharmacokinetics and safety of a novel anti-HBs enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration","volume":"62","author":"Th\u00fcrmann","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/tri.13112-BIB0026|tri13112-cit-0026","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1665-2681(19)31656-4","article-title":"Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence","volume":"9","author":"Singham","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1111\/tri.13112-BIB0027|tri13112-cit-0027","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1432-2277.2011.01222.x","article-title":"Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra) in liver transplantation: an open, prospective, single-arm phase III study","volume":"24","author":"Yahyazadeh","year":"2011","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13112-BIB0028|tri13112-cit-0028","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-6143.2012.04319.x","article-title":"Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study","volume":"13","author":"Di Costanzo","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13112-BIB0029|tri13112-cit-0029","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1111\/tri.13112-BIB0030|tri13112-cit-0030","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1158\/0008-5472.CAN-11-2260","article-title":"Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src\/PI3K\/Akt pathway","volume":"71","author":"Liu","year":"2011","journal-title":"Cancer Res"},{"key":"10.1111\/tri.13112-BIB0031|tri13112-cit-0031","doi-asserted-by":"crossref","first-page":"15704","DOI":"10.18632\/oncotarget.14944","article-title":"Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro","volume":"8","author":"Salpini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1111\/tri.13112-BIB0032|tri13112-cit-0032","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/hepr.12444","article-title":"Effect of serum hepatitis B surface antigen levels on predicting the clinical outcomes of chronic hepatitis B infection: a meta-analysis","volume":"45","author":"Qu","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1111\/tri.13112-BIB0033|tri13112-cit-0033","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/apt.13634","article-title":"Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance","volume":"43","author":"Liu","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/tri.13112-BIB0034|tri13112-cit-0034","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1499-3872(16)60064-4","article-title":"Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis","volume":"15","author":"Wang","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1111\/tri.13112-BIB0035|tri13112-cit-0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.7150\/ijms.5795","article-title":"Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with Lamivudine","volume":"10","author":"Kamezaki","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1111\/tri.13112-BIB0036|tri13112-cit-0036","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2893.2011.01494.x","article-title":"Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs","volume":"19","author":"Chotiyaputta","year":"2012","journal-title":"J Viral Hepat"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.13112","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.13112\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:40:34Z","timestamp":1641062434000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.13112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.13112","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,2]]}}}